RS Oncology LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma (NCT05278975) | RS Oncology LLC | 2022-03-31 |
Track RS Oncology LLC automatically
Every clearance here is in the API, with alerts when new ones post.